You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Twitter Demographics
Mendeley readers
Attention Score in Context
| Title |
Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis)
|
|---|---|
| Published in |
Cochrane database of systematic reviews, November 2011
|
| DOI | 10.1002/14651858.cd008872.pub2 |
| Pubmed ID | |
| Authors |
Alexandra N Colebatch, Jonathan L Marks, Christopher J Edwards |
| Abstract |
Methotrexate is routinely used in the treatment of inflammatory arthritis. There have been concerns regarding the safety of using concurrent non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin, or paracetamol (acetaminophen), or both, in these people. |
Twitter Demographics
The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 1 | 50% |
| Brazil | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 238 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 2 | <1% |
| United States | 2 | <1% |
| Chile | 1 | <1% |
| Brazil | 1 | <1% |
| Australia | 1 | <1% |
| Sri Lanka | 1 | <1% |
| United Kingdom | 1 | <1% |
| Unknown | 229 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 37 | 16% |
| Student > Master | 34 | 14% |
| Student > Bachelor | 29 | 12% |
| Student > Ph. D. Student | 23 | 10% |
| Other | 12 | 5% |
| Other | 37 | 16% |
| Unknown | 66 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 90 | 38% |
| Pharmacology, Toxicology and Pharmaceutical Science | 16 | 7% |
| Nursing and Health Professions | 16 | 7% |
| Psychology | 9 | 4% |
| Agricultural and Biological Sciences | 7 | 3% |
| Other | 27 | 11% |
| Unknown | 73 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 June 2023.
All research outputs
#1,864,300
of 22,805,349 outputs
Outputs from Cochrane database of systematic reviews
#4,138
of 12,315 outputs
Outputs of similar age
#9,831
of 143,064 outputs
Outputs of similar age from Cochrane database of systematic reviews
#43
of 154 outputs
Altmetric has tracked 22,805,349 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,315 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.4. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 143,064 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 154 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.